Swiss National Bank - VANDA PHARMACEUTICALS INC ownership

VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 180 filers reported holding VANDA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 3.16 and the average weighting 0.0%.

Quarter-by-quarter ownership
Swiss National Bank ownership history of VANDA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$545,616
-32.2%
126,300
+3.4%
0.00%
-100.0%
Q2 2023$805,298
-2.9%
122,2000.0%0.00%0.0%
Q1 2023$829,738
-17.8%
122,200
-10.5%
0.00%0.0%
Q4 2022$1,009,474
-23.8%
136,600
+1.9%
0.00%0.0%
Q3 2022$1,324,000
-7.8%
134,000
+1.7%
0.00%0.0%
Q2 2022$1,436,000
-3.6%
131,7000.0%0.00%0.0%
Q1 2022$1,490,000
-22.7%
131,700
+7.2%
0.00%0.0%
Q4 2021$1,927,000
-8.5%
122,8000.0%0.00%0.0%
Q3 2021$2,105,000
-19.1%
122,800
+1.5%
0.00%
-50.0%
Q2 2021$2,603,000
+38.6%
121,000
-3.2%
0.00%
+100.0%
Q1 2021$1,878,000
+15.6%
125,000
+1.1%
0.00%0.0%
Q4 2020$1,624,000
+36.0%
123,6000.0%0.00%0.0%
Q3 2020$1,194,000
-12.9%
123,600
+3.2%
0.00%0.0%
Q2 2020$1,371,000
+42.1%
119,800
+28.7%
0.00%0.0%
Q1 2020$965,000
-35.9%
93,100
+1.4%
0.00%
-50.0%
Q4 2019$1,506,000
+26.7%
91,800
+2.6%
0.00%
+100.0%
Q3 2019$1,189,000
-4.2%
89,500
+1.6%
0.00%0.0%
Q2 2019$1,241,000
-29.4%
88,100
-7.7%
0.00%
-50.0%
Q1 2019$1,757,000
-27.4%
95,500
+3.1%
0.00%
-33.3%
Q4 2018$2,420,000
+18.5%
92,600
+4.0%
0.00%
+50.0%
Q3 2018$2,043,000
+20.5%
89,0000.0%0.00%0.0%
Q2 2018$1,695,000
+13.0%
89,0000.0%0.00%0.0%
Q1 2018$1,500,000
+42.0%
89,000
+28.1%
0.00%
+100.0%
Q4 2017$1,056,000
-15.1%
69,5000.0%0.00%0.0%
Q3 2017$1,244,000
+9.8%
69,5000.0%0.00%0.0%
Q2 2017$1,133,000
+27.6%
69,500
+9.6%
0.00%0.0%
Q1 2017$888,000
-12.2%
63,4000.0%0.00%
-50.0%
Q4 2016$1,011,000
-4.2%
63,4000.0%0.00%0.0%
Q3 2016$1,055,000
+48.8%
63,4000.0%0.00%
+100.0%
Q2 2016$709,000
+31.8%
63,400
-4.9%
0.00%0.0%
Q1 2016$538,000
+7.8%
66,700
+24.4%
0.00%0.0%
Q4 2015$499,000
-17.5%
53,6000.0%0.00%
-50.0%
Q3 2015$605,000
+7.8%
53,600
+21.3%
0.00%
+100.0%
Q2 2015$561,000
+43.1%
44,200
+4.7%
0.00%0.0%
Q1 2015$392,000
-35.1%
42,2000.0%0.00%
-50.0%
Q4 2014$604,000
+53.3%
42,200
+11.1%
0.00%0.0%
Q3 2014$394,000
-35.9%
38,0000.0%0.00%0.0%
Q2 2014$615,00038,0000.00%
Other shareholders
VANDA PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Palo Alto Investors LP 2,491,200$27,154,0002.37%
Profit Investment Management, LLC 281,890$3,071,0002.26%
Sio Capital Management, LLC 488,965$5,330,0002.00%
Zebra Capital Management LLC 14,766$161,0000.47%
Prairiewood Capital, LLC 50,165$547,0000.43%
TANG CAPITAL MANAGEMENT LLC 256,696$2,798,0000.42%
HUSSMAN STRATEGIC ADVISORS, INC. 156,000$1,700,0000.29%
GLOBEFLEX CAPITAL L P 100,843$1,099,0000.27%
Epoch Investment Partners, Inc. 2,757,646$30,059,0000.18%
EMC Capital Management 16,185$176,0000.15%
View complete list of VANDA PHARMACEUTICALS INC shareholders